Neurochemical Research Launches Male Virility to Enhance Sexual Performance; An All-Natural Alternative With No Known Side Effects

Business Wire, Feb 4, 2002

Neurochemical Research Corp. (Pink Sheets:NCRH), a marketer of condition-specific dietary supplements, has announced the launch of Male Virility(TM), an alternative product designed to optimize sexual fitness for men who are unable to tolerate popular impotence medications because of side effects.

Providing nutrients for better sex, Male Virility is aimed at 67 percent of the male population who suffer from some degree of erectile dysfunction (ED). Carol Slavin, president, said, "Although ED is strongly associated with aging (published literature suggests organs begin to wear out after the age of 30), it is actually associated with medical conditions such as heart disease. Physicians warn that Viagra(R), the most well-known pill for impotence with more than 10 million prescriptions and 2 billion plus in sales, has side effects."

Male Virility is just one of a group of highly sophisticated products Neurochemical Research will bring to the multibillion-dollar botanical market (2000 sales hit 1.6 billion and annual growth rate is at 18.7%) under the banner of providing natural alternatives, without side effects, to treat health conditions.

About Neurochemical Research

Among the Company's complex, highly technical nutritional intervention products is a compelling product for macular degeneration sufferers, VisionKare(TM). A recent National Eye Institute study found that high levels of antioxidants and zinc found in the VisionKare product significantly reduce the risk of advanced age-related macular degeneration (AMD) and its associated vision loss. For more information on the Company and to view its product line, visit the company's Website at www.nrccorp.net or call Investor Relations at Euro Pacific Capital Corp., Steven McDonald, Toll Free: 1-888-702-4478.

DISCLOSURE NOTICE: The Company assumes no obligation to update any forward-looking statements contained in this document as a result of new information or future events or development. This document contains forward-looking information about the Company's business prospects that involve substantial risks and uncertainties.

COPYRIGHT 2002 Business Wire COPYRIGHT 2002 Gale Group